Review



mhz microscan transducer  (FUJIFILM VisualSonics Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    FUJIFILM VisualSonics Inc mhz microscan transducer
    Mhz Microscan Transducer, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/pm41807690-218-17-8
    Average 86 stars, based on 1 article reviews
    mhz microscan transducer - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Divergent roles of endothelial and red blood cell nitric oxide synthase in regulating cardiovascular function during anemia.
    Article Snippet: Left ventricular (LV) function was assessed before and after AMI in mice anesthetized with 2.5 % isoflurane in 100 % oxygen, using transthoracic echocardiography using vevo 2100 (18–38 MHz; Visual Sonics Inc., Toronto, Canada), as previously described [28].

    Article Title: 27 ULTRASOUND, SPOT TEST, BLADDER LEAKAGE CAPACITY, AND TIME TO LEAKAGE TO DETERMINE THE FUNCTIONAL ALTERATION IN DIFFERENT RAT MODELS OF STRESS URINARY INCONTINENCE
    Article Snippet: INTRODUCTION AND OBJECTIVES: Caveolae are small invaginations of the cell membrane that are thought to be important in cell surface signaling.. The purpose of this study was to investigate the effect of ovariectomy induced bladder overactivity on the expression of caveolin 2 and 3 of the detrusor smooth muscle of the urinary bladder in rats.. METHODS: Female Sprague-Dawley rats were divided into three groups: control, bilateral ovariectomy (Ovx), and bilateral ovariectomy followed by subcutaneous injections of 17 -estradiol (Ovx Est).

    Article Title: Cardiometabolic adaptations in the cave nectar bat Eonycteris spelaea.
    Article Snippet: Echocardiography was performed using a Vevo 2100 system (Visual Sonics Inc., Toronto, Canada) equipped with a 38 MHz MicroScan transducer (frequency range 18-38 MHz) at the SingHealth Experimental Medicine Centre (SEMC).

    Article Title: Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca 2+ channel.
    Article Snippet: The left-ventricular systole and diastole were recorded using a high-resolution ultrasound system (18–38 MHz; Vevo 3100, Visual Sonics Inc., Toronto, Canada).



    Similar Products

    microscan walkaway 40 system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 40 system
    Microscan Walkaway 40 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system+walkaway/pm41943907-54-11-15
    Average 86 stars, based on 1 article reviews
    microscan walkaway 40 system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    microscan autoscan 4 system  (Dade Behring)
    86
    Dade Behring microscan autoscan 4 system
    Microscan Autoscan 4 System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system/pm41942599-48-13-17
    Average 86 stars, based on 1 article reviews
    microscan autoscan 4 system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    mhz microscan transducer  (FUJIFILM VisualSonics Inc)
    86
    FUJIFILM VisualSonics Inc mhz microscan transducer
    Mhz Microscan Transducer, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/pm41807690-218-17-8
    Average 86 stars, based on 1 article reviews
    mhz microscan transducer - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    microscan walkway 96 system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkway 96 system
    Microscan Walkway 96 System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/pmc13006696-46-13-17
    Average 86 stars, based on 1 article reviews
    microscan walkway 96 system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    microscan walkaway 96 plus automated microbial susceptibility system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 96 plus automated microbial susceptibility system
    Microscan Walkaway 96 Plus Automated Microbial Susceptibility System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/pmc12997785-33-5-13
    Average 86 stars, based on 1 article reviews
    microscan walkaway 96 plus automated microbial susceptibility system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    mhz microscan linear ultrasound imaging array  (FUJIFILM VisualSonics Inc)
    86
    FUJIFILM VisualSonics Inc mhz microscan linear ultrasound imaging array
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Mhz Microscan Linear Ultrasound Imaging Array, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/bio_rxiv__64898__2026__03__02__708396-201-26-33
    Average 86 stars, based on 1 article reviews
    mhz microscan linear ultrasound imaging array - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    microscan walkaway 96 plus system  (Siemens Healthineers)
    86
    Siemens Healthineers microscan walkaway 96 plus system
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Microscan Walkaway 96 Plus System, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/96+instrument+walkaway/bio_rxiv__64898__2025__12__30__696967-48-10-14
    Average 86 stars, based on 1 article reviews
    microscan walkaway 96 plus system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    microscan system  (Dade Behring)
    86
    Dade Behring microscan system
    (A) CAD rendering of custom <t>ultrasound-guided</t> FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz <t>MicroScan</t> linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.
    Microscan System, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/microscan/microscan+system/pm41387691-161-8-10
    Average 86 stars, based on 1 article reviews
    microscan system - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

    Journal: bioRxiv

    Article Title: Focused Ultrasound Thermal Ablation and CD40 Agonism Reprograms Breast Tumor Immunity to Drive Regression and Memory

    doi: 10.64898/2026.03.02.708396

    Figure Lengend Snippet: (A) CAD rendering of custom ultrasound-guided FUS system consisting of a 4-element 3.78 MHz transducer axially co-registered with 15 MHz MicroScan linear ultrasound imaging array. (B) Representative partial ablation scheme and (C) B-mode ultrasound images of E0771 tumor either before/during (top) or after (bottom) T-FUS treatment, with hyperechoic signature present after treatment (arrow). (D) Custom grading scale of presence of hyperechoic signal post-T-FUS treatment across all murine breast cancer models. (E) Overview of experimental timeline. (F) Representative H&E staining, along with cleaved caspase 3, PARP, and HSP70 staining, was performed on control and T-FUS-treated E0771 tumors 24 hours post-treatment. (G) In vivo surrogate measurements of ATP levels via bioluminescence at 10 minutes after T-FUS. (H) Temporal radiance curve (proxying relative ATP levels) for a sham vs. tumor volume-matched T-FUS mice (E0771 model). Significance assessed by Wilcoxon rank-sum test. **p=0.0028. H-L) (I) Percentage of B cells (CD19 + , MHCII + ), (J) macrophages (MФs; F480 + , Ly6C - ), (K) cDCs (CD11c + , MHCII + ), (L) monocytes (F480 + , Ly6C + ), and (M) granulocytes (CD11b + , Ly6G + ) out of CD45+ cells in the tumor. Significance assessed by Welch’s T-test.*p < 0.05, **p < 0.01, and ***p < 0.001 vs. control, respectively.

    Article Snippet: The system was powered by a 200W amplifier (Electronics & Innovation 1020L) driven by an arbitrary function generator (Tektronix AFG3022C), and axially co-registered to a 15 MHz MicroScan linear ultrasound imaging array (MS200; VisualSonics).

    Techniques: Imaging, Staining, Control, In Vivo